Shopping Cart
- Remove All
- Your shopping cart is currently empty
E28362, a small molecule PCSK9 inhibitor, blocks the interaction between PCSK9 and LDLR, thereby preventing the degradation of LDLR and maintaining cholesterol homeostasis. As a promising lead compound, E28362 is utilized in research related to hyperlipidemia and atherosclerosis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | E28362, a small molecule PCSK9 inhibitor, blocks the interaction between PCSK9 and LDLR, thereby preventing the degradation of LDLR and maintaining cholesterol homeostasis. As a promising lead compound, E28362 is utilized in research related to hyperlipidemia and atherosclerosis. |
Molecular Weight | 301.34 |
Formula | C16H19N3O3 |
Cas No. | 930017-01-9 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.